These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 3552295

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA, Minar E, Brenner B, Eichler HG, Heistinger M, Marosi L, Lechner K.
    Thromb Haemost; 1989 Jun 30; 61(3):374-7. PubMed ID: 2508252
    [Abstract] [Full Text] [Related]

  • 3. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C, Rivoltella L, Martelli L, Valzacchi S, Fanelli R.
    Biochim Biophys Acta; 1992 Feb 03; 1133(3):247-54. PubMed ID: 1737057
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
    Preston FE, Whipps S, Jackson CA, French AJ, Wyld PJ, Stoddard CJ.
    N Engl J Med; 1981 Jan 08; 304(2):76-9. PubMed ID: 7003384
    [Abstract] [Full Text] [Related]

  • 7. The effect of regular and enteric-coated aspirin on bleeding time, thromboxane, and prostacyclin.
    Gow JA, Ebbeling L, Gerrard JM.
    Prostaglandins Leukot Essent Fatty Acids; 1993 Jul 08; 49(1):515-20. PubMed ID: 8361987
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL, Mehta P, Lopez L, Ostrowski N, Aguila E.
    J Am Coll Cardiol; 1984 Oct 08; 4(4):806-11. PubMed ID: 6384329
    [Abstract] [Full Text] [Related]

  • 10. In vivo measurement of thromboxane B2 and 6-keto-prostaglandin F1 alpha in humans in response to a standardized vascular injury and the influence of aspirin.
    Gerrard JM, Taback S, Singhroy S, Docherty JC, Kostolansky I, McNicol A, Kobrinsky NL, McKenzie JK, Rowe R.
    Circulation; 1989 Jan 08; 79(1):29-38. PubMed ID: 2910545
    [Abstract] [Full Text] [Related]

  • 11. Effect of single-dose aspirin on TXA2 and PGI2 cyclooxygenases in vivo.
    Zaragoza R, Le Breton GC.
    Haemostasis; 1987 Jan 08; 17(1-2):40-8. PubMed ID: 3110025
    [Abstract] [Full Text] [Related]

  • 12. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
    Kyrle PA, Stockenhuber F, Brenner B, Gössinger H, Korninger C, Pabinger I, Sunder-Plassmann G, Balcke P, Lechner K.
    Thromb Haemost; 1988 Oct 31; 60(2):205-8. PubMed ID: 2975407
    [Abstract] [Full Text] [Related]

  • 13. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O, Mäkilä UM, Viinikka L.
    Br J Obstet Gynaecol; 1983 Mar 31; 90(3):251-4. PubMed ID: 6338904
    [Abstract] [Full Text] [Related]

  • 14. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
    Nowak J, FitzGerald GA.
    J Clin Invest; 1989 Feb 31; 83(2):380-5. PubMed ID: 2643628
    [Abstract] [Full Text] [Related]

  • 15. Differential inhibition of platelet thromboxane and lung prostacyclin production by sulphinpyrazone, acetylsalicylic acid and indomethacin by human tissues in vitro.
    Toivanen J, Ylikorkala O, Viinikka L.
    Thromb Res; 1985 Feb 15; 37(4):493-502. PubMed ID: 3920778
    [Abstract] [Full Text] [Related]

  • 16. In vivo formation of prostacyclin and thromboxane A2 at the site of platelet-vascular interaction in humans.
    Nowak J, FitzGerald GA.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Feb 15; 17A():208-11. PubMed ID: 2959050
    [No Abstract] [Full Text] [Related]

  • 17. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis.
    Keimowitz RM, Pulvermacher G, Mayo G, Fitzgerald DJ.
    Circulation; 1993 Aug 15; 88(2):556-61. PubMed ID: 8339418
    [Abstract] [Full Text] [Related]

  • 18. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    Livio M, Benigni A, Zoja C, Begnis R, Morelli C, Rossini M, Garattini S, Remuzzi G.
    J Pharmacol Exp Ther; 1989 Jan 15; 248(1):334-41. PubMed ID: 2492341
    [Abstract] [Full Text] [Related]

  • 19. Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.
    Clarke RJ, Mayo G, Price P, FitzGerald GA.
    N Engl J Med; 1991 Oct 17; 325(16):1137-41. PubMed ID: 1891022
    [Abstract] [Full Text] [Related]

  • 20. Effect of conjugated estrogens on platelet function and prostacyclin generation in CRF.
    Heistinger M, Stockenhuber F, Schneider B, Pabinger I, Brenner B, Wagner B, Balcke P, Lechner K, Kyrle PA.
    Kidney Int; 1990 Dec 17; 38(6):1181-6. PubMed ID: 1963650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.